Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Why TikTok Keeps You Scrolling: Baylor Research Explains the Science Behind Social Media Addiction
Why is it so hard to stop scrolling TikTok? A new study by Baylor University marketing professors and social media researchers James A. Roberts, Ph.D. and Meredith E. David, Ph.D., reveals that the answer lies not only in the app’s content, but in its design. Their research, published in the journal Cyberpsychology, Behavior, and Social Networking, is among the first to compare the technological affordances – the built-in design features that shape user behavior – of three leading short-form video (SFV) platforms: TikTok, Instagram Reels and YouTube Shorts. The findings reveal that TikTok’s combination of ease of use, highly accurate recommendations and surprising content variety creates a powerful recipe for user engagement – and, in many cases, addiction. The power of effortless design In their study, Roberts and David had participants rate each platform on three key technological affordances: perceived effortlessness, recommendation accuracy and serendipity (the element of surprise) and answer questions measuring their levels of social media engagement and addictive use. The results were clear: TikTok scored significantly higher than Instagram Reels or YouTube Shorts across all categories. Users in the study said TikTok required the least effort to use, delivered the most relevant videos and surprised them most often with unexpected but enjoyable content. “It’s the combination of all three that keeps people scrolling,” David said. “But the prerequisite is effortlessness. Without that ease of use, the other two wouldn’t matter as much.” TikTok’s seamless experience – where videos begin playing automatically the moment the app opens – creates a sense of immersion unmatched by competitors. Other platforms require users to click or select a video before viewing begins, a subtle difference that nonetheless makes TikTok feel faster and more intuitive. Engagement becomes addiction The study found that TikTok’s technological affordances indirectly increase addiction by first increasing engagement. The more users engage, the more likely they are to lose track of time – a phenomenon known as time distortion. David said this design is no accident. “TikTok’s algorithm is intentionally created to be addictive,” she said. “Their own materials acknowledge that users can become hooked after less than half an hour on the app.” She noted that even users who recognize these patterns often underestimate how long they spend scrolling. “We all need to be more cognizant of our time on these platforms,” David said. “Check your phone’s screen-time data – you may be surprised.” Implications for users and policy Beyond individual awareness, the researchers point to the broader social impact of overuse – particularly for young people. Excessive time on short-form video apps can erode attention spans, foster expectations for instant gratification and displace face-to-face interaction. “These platforms are designed to hold our attention,” David said. “But the opportunity cost is huge. The more time we spend scrolling, the less time we have for the activities that build real connection and meaning.”
How mitochondria shape brain health from childhood to old age
From the first spark of neural development to the challenges of ageing, Dr Lissette Sánchez Aranguren is uncovering how the cell’s powerhouses — mitochondria — hold the key to a healthy brain across the human lifespan. Her pioneering research at Aston University explores how these microscopic energy generators safeguard the brain’s communication network and how their dysfunction may underlie conditions such as dementia, stroke, and neurodevelopmental disorders. Mapping the brain’s energy defence system Dr Sánchez Aranguren’s work focuses on the partnership between brain cells and the blood vessels that nourish them — a relationship maintained by the blood–brain barrier. When mitochondria fail, that protective interface can weaken, allowing harmful molecules to penetrate and trigger inflammation or cell loss. Her team’s studies show that mitochondrial malfunction disrupts the dialogue between neurons and vascular cells, an imbalance seen both in the developing and ageing brain. To counter this, she and her collaborators have engineered a mitochondria-targeted liposome, a nanoscale “bubble” that delivers restorative molecules directly where they are needed most. By re-balancing cellular energy and communication, this innovation could one day reduce brain injury or slow neurodegenerative decline. From heart cells to the human mind Originally trained in cardiovascular science, Dr Sánchez Aranguren became fascinated by how mitochondria regulate energy and stress in blood-vessel cells — insights that ultimately led her toward neuroscience. View her profile here “Mitochondria do much more than produce energy. They send signals that determine how cells communicate and survive.” That realisation inspired her to trace mitochondrial signalling across the continuum of life — linking early brain development to later-life vulnerability. Her research now bridges traditionally separate fields of developmental biology, vascular physiology, and ageing neuroscience, helping identify shared molecular pathways that influence lifelong brain resilience. Global collaboration for a healthier brain Her work thrives on multidisciplinary and international partnerships. At Aston, she collaborates with scientists from Coventry University, Queen’s University Belfast, and the University of Lincoln, alongside research partners in the Netherlands, Italy, Malaysia, and China. Together they integrate chemistry, biology, and computational modelling to understand mitochondrial function from molecule to organism — and translate discoveries into practical therapies. Towards mitochondria-targeted brain therapies The next frontier is refining these mitochondria-targeted nanocarriers to enhance precision and efficacy in preclinical models, while exploring how mitochondrial signals shape the brain’s vascular and neural architecture from infancy through adulthood. Dr Sánchez Aranguren envisions a future where protecting mitochondrial health becomes central to preventing brain disease, shifting medicine from managing symptoms to preserving the brain’s natural defence and repair systems. “If we can protect the cell’s own energy engines,” she says, “we can give the brain its best chance to stay healthy for life.”
Black Friday 2025: Earlier, Bigger and More Digital Than Ever
Black Friday is no longer just a day – it’s becoming an entire season. In 2025, shoppers are starting earlier, spending more and relying heavily on technology to find the best deals. With online shopping now the dominant force, an estimated 71% of consumers plan to browse and buy from their screens rather than stand in long lines. Baylor University consumer behavior expert James A. Roberts, Ph.D., said this year’s sales stretch well beyond Thanksgiving weekend. Top 5 Black Friday Trends from Dr. James A. Roberts Retailers have pushed promotions into early November – and in some cases, late October – creating what many now call “Black November.” And for the true procrastinators, “Desperate in December” is the new reality, with next-day delivery extending holiday shopping right up to the last minute. Even as shoppers plan to spend up to 10% more, they’re extremely price sensitive, Roberts said. Inflation, rising living costs and ongoing economic uncertainty – including concerns over tariffs – are prompting consumers to hunt for deeper discounts and compare prices more closely than ever. That caution is also fueling another trend: increased use of buy-now-pay-later plans. While convenient, Roberts urges shoppers to approach them carefully to avoid overspending. Technology also is accelerating the shift. AI tools and retail chatbots are helping customers track deals and make purchases, while influencers and social media ads continue to shape buying habits. Cost-conscious platforms like Temu and Shein are poised for another strong season. Clothing, electronics and home goods remain top categories, Roberts said, with gift cards still the go-to for last-minute buyers. Walmart, Target and Kohl’s are expected to be the most popular in-store destinations, while Amazon – unsurprisingly – continues to dominate Cyber Monday. Overall spending remains robust. Shoppers are expected to spend roughly $20 billion across online and in-store purchases, split almost evenly between the two. The best bargains will be toys discounted about 25 percent, phones and computers discounted around 30 percent and TVs discounted an average of 23 percent. The typical shopper will spend about $650 this holiday weekend. How to navigate the shopping frenzy Roberts offers some simple advice for navigating the frenzy: Set a budget, stick to it, choose thoughtful gifts and keep the season in perspective. After all, the most meaningful gifts are the ones that show how well you know the people you love. ABOUT JAMES A. ROBERTS, PH.D. James A. Roberts, Ph.D., is The Ben H. Williams Professor of Marketing at Baylor University’s Hankamer School of Business. A noted consumer behavior expert, he is among the Top 2% Most-Cited Researchers in a database compiled by Stanford University. In addition to journal citations, Roberts has often been called upon by national media outlets for his consumer expertise and latest research. He has appeared on the CBS Early Show, ABC World News Tonight, ABC Good Morning America, NBC’s TODAY Show and NPR’s Morning Edition, as well as in articles in The New York Times, USA TODAY, The Wall Street Journal, TIME and many others. Roberts’ research has focused on how individual consumer attitudes and behavior impact personal and collective well-being, including investigating the factors that drive ecologically and socially conscious consumer behavior, the impact of materialism and compulsive buying on well-being and the effect of smartphone and social media use on personal well-being. He is the author of “Shiny Objects: Why We Spend Money We Don’t Have in Search of Happiness We Can’t Buy” and “Too Much of a Good Thing: Are You Addicted to Your Smartphone?”
ChristianaCare Launches Organoid Core to Personalize Cancer Treatment
ChristianaCare’s Cawley Center for Translational Cancer Research has unveiled a first-of-its-kind organoid core in a community cancer center program. The new laboratory facility within the Helen F. Graham Cancer Center & Research Institute grows and tests living, patient-derived tumor models, giving doctors and researchers a faster, more precise way to identify the therapies most likely to work for each patient. This innovation could change how cancer is treated in Delaware and serve as a model for community centers nationwide. There are only a handful of organoid core centers, or “tumor-on-a-chip” programs, in the United States, and ChristianaCare’s is the first within a community cancer center setting. What the Organoid Core Does Tumor organoids are tiny, three-dimensional cultures grown from a patient’s tumor tissue. They preserve the genetic and molecular traits of the original tumor, making them far more accurate than traditional cell lines. “These mini-tumors enable researchers to screen drugs faster, identify new biomarkers and discover which treatments are most likely to work for each patient,” said Thomas Schwaab, M.D., Ph.D., Bank of America Endowed Medical Director of ChristianaCare’s Helen F. Graham Cancer Center and Research Institute. “This core is a bridge between the lab and the clinic. By growing living tumor models from cells of individual patients, we can test real-world drug responses and tailor treatments for them in ways that were not possible before.” How It Advances Patient Care The organoid core strengthens the Cawley Center's research capabilities by enabling drug screening and biomarker discovery. It will bank organoids representing the wide variety of tumors seen in the community, giving scientists a realistic system for testing therapies. ChristianaCare treats more than 70 percent of cancer patients in Delaware, giving researchers unique access to treatment-naïve samples. These are tumor tissues that have not yet been exposed to chemotherapy or other therapies. Studying them provides a more accurate picture of how cancer behaves naturally and how it might respond to new treatments. Bringing a new cancer drug to patients is expensive and risky. Estimates show it can cost $1.3 to $2.8 billion, with up to a third spent on preclinical development, and only about one in 10 compounds ever reach human trials. Traditional mouse models often fail to fully mimic human tumors, making early testing less reliable. By using organoid screening, the Cawley Center can test therapies more accurately, reduce costs and failure rates and move promising treatments into clinical trials faster. Combined with existing tissue collection programs, clinical trial infrastructure and community partnerships, these resources create a direct pathway to bring lab discoveries to patients faster. Turning Point in Translational Research “Our goal is to shorten the distance between discovery and treatment,” said Nicholas J. Petrelli, M.D., director of the Cawley Center. “Too many promising drugs fail because early models do not capture the complexity of real tumors. The organoid core helps solve that problem. We can now test therapies in models that reflect the patients we actually serve.” “This is a turning point for translational research in community health,” said Jennifer Sims Mourtada, Ph.D., associate director at the Cawley Center. “Organoid technology lets us study cancer in a way that feels personal. We are not just looking at data points. We are studying living models of a patient’s tumor, which can reveal how that person’s cancer might behave or respond to treatment. This approach brings science closer to the people it is meant to help.” Looking Ahead In the coming months, the organoid core will focus on building a diverse biobank of tumors common in Delaware. Plans include collaborations with academic institutions, shared access for external researchers, and development of immune-tumor co-culture models. By combining advanced technology, strong community partnerships and direct patient access, ChristianaCare and the Cawley Center are showing how translational cancer research can thrive in a community setting, making breakthroughs not only in the lab but also in patients’ lives.
Breakthrough with first disease-resistant wine grapes shows hope for a Florida wine renaissance
In a milestone for Florida agriculture, researchers have grown and harvested wine grapes that are resistant to the main bacterial disease that has long prevented the state from establishing a large-scale wine industry. Researchers successfully grew five grape varieties in Citra, Florida, that are resistant to Pierce’s disease, a bacterial infection that kills the vines and shrivels the grapes. The effort, led by Ali Sarkhosh, associate professor in the UF Institute of Food and Agricultural Sciences (UF/IFAS) horticultural sciences department, produced a harvest of grapes that resulted in 13 cases of wine. “This could be the start of a new chapter for Florida wine.” — Ali Sarkhosh, associate professor in the UF Institute of Food and Agricultural Sciences horticultural sciences department While Florida has a thriving muscadine grape industry, the global market for muscadine wine is small compared to wine made from Vitis vinifera, the species of grapes behind world-famous wines such as cabernet sauvignon, sauvignon blanc and merlot. Florida is already the nation’s second-highest wine-consuming state, behind only California, with an industry valued at $15 billion in 2022. Yet most of the wines served are produced elsewhere, primarily in California, Oregon and Washington. Sarkhosh said he hopes this research will offer a potential additional crop for muscadine grape farmers. As of 2017, there were 547 Florida vineyards, growing muscadine and hybrid grapes. “This could be an enormous opportunity for vineyards in Florida to expand into additional types of wine for a wider market,” he said. “This could be the start of a new chapter for Florida wine.” UF researchers worked with Château Le Coeur, a winery based in DeFuniak Springs, Florida, to make the wine from their harvest. The wine was crafted with 75% Florida-grown fruit and blended with 25% cabernet sauvignon and merlot. The grape used in the wine collaboration is a hybrid called “Erante Noir” and was developed at the University of California, Davis. It carries the genes of sauvignon blanc and cabernet sauvignon. John Choquer, the owner of Château Le Coeur, emphasized the potential for this collaboration. “If we are successful in growing in the area and combating Pierce’s disease effectively, it will be a strong growth industry and emerging market for agri-tourism,” he said. Early tastings point to a dark, fruit-forward wine. Château Le Coeur named this debut wine “Genial,” a French expression for something new and innovative. He said he is also planting a variety of traditional wine grapes, red and white, at his vineyard. He said his winery is grateful for UF’s support and collaboration as he works to create a Florida-based traditional wine industry. “This is not a short-term experiment,” Choquer added. “We plan to test more Pierce’s disease-resistant and traditional vinifera varieties, refine vineyard practices and build a new type of wine industry here in Florida. There will be challenges, there will be setbacks, but the potential is also so great. There is such a strong market potential here in Florida.”
RPI Hosts Launch Event for New Center for Smart Convergent Manufacturing Systems
Rensselaer Polytechnic Institute (RPI) officially cut the ribbon on its new Center for Smart Convergent Manufacturing Systems (CSCMS) during an all-day launch event on October 23, 2025. A New York State Center for Advanced Technology, CSCMS will redefine the very nature of manufacturing by combining robotics, artificial intelligence, advanced processing, and human ingenuity to create systems that think, adapt, and evolve alongside human operators. “Today we mark the official opening of a center with a bold vision: a future where manufacturing systems are not simply automated, but truly intelligent,” said RPI President Martin A. Schmidt ’81 during the ribbon cutting. CSCMS will bring a wealth of opportunities not only to RPI, but across New York State. The new center will serve as a catalyst for economic growth, empowering innovators, driving new technologies, and strengthening the competitiveness of manufacturers. At RPI, students will gain hands-on experience in labs, real-world projects, and entrepreneurial pathways. Faculty and industry partners will gain the resources to translate cutting-edge research into commercial solutions. “Through simulation, prototyping, and translational research, our faculty and students will work side by side with industry and government to accelerate the development and deployment of smart manufacturing solutions,” said President Schmidt. “This is the RPI model at its very best: turning ideas into impact.” The launch event for CSCMS took place on RPI’s campus and featured keynote remarks, a ribbon cutting, industry panel, poster sessions, lab tours, and demonstrations of robotic manufacturing, human-machine collaboration, smart manufacturing testbeds, intelligent production systems, and data visualization spaces. Industry panel speakers included executives from FuzeHub, Ross Precision Manufacturing, GE Aerospace Research, and The Boeing Company. Interactive student poster sessions covered topics such as robotics, AI, advanced manufacturing, and New York’s future at the convergence of these topics. “The launch of CSCMS comes at a pivotal time for manufacturing,” said Johnson Samuel, Ph.D., director of CSCMS. “Across industries, we are seeing the convergence of AI, robotics, and data-driven design transforming how products are made. RPI’s long-standing strengths in engineering, computing, and innovation make it the perfect home for this next-generation center.” “The energy and collaboration we saw during this event are a reflection of the momentum behind the entire CSCMS initiative,” said Sandipan Mishra, Ph.D., associate director of CSCMS. “This launch is the start of a sustained effort to shape the future of intelligent manufacturing in New York and beyond.” "It's exciting that as students, we get to work with these cutting-edge technologies up close and be a part of something that’s pushing manufacturing forward,” said RPI graduate student Ammar Barbee ‘25, who recently completed his bachelor’s degree in mechanical engineering at RPI. “Perusing this kind of research and having access to such advanced equipment enables unique experiences that will really help accelerate our careers.” With the launch of CSCMS, RPI continues to advance its legacy of innovation and partnership, bringing together academia, industry, and government to drive progress in intelligent manufacturing and strengthen New York’s position as a hub for technological excellence.
RPI Awarded Air Force Grant to Monitor Growing Traffic Between Earth and Moon
As nations and private companies prepare to ramp up the number of missions to the Moon, researchers at Rensselaer Polytechnic Institute (RPI) and Texas A&M University have secured a $1 million grant from the Air Force Office of Scientific Research to develop a system to track and monitor resident space objects — including spacecraft, satellites and debris — moving through the vast cislunar space between the Earth and the Moon. The initiative, called RCAT-CS (Reconfigurable Constellations for Adaptive Tracking in Cislunar Space), will develop intelligent networks of sensor satellites that can be reconfigured to perform resilient tracking of objects as they maneuver through this complex orbital environment. "Right now, we're seeing an explosive growth in cislunar missions, including everything from commercial lunar landers and orbiters to next-generation spacecraft that secure national interests in this contested domain," said engineering professor Sandeep Singh, Ph.D., RPI’s lead investigator on the project. "But our ability to track what's happening out there hasn't kept pace. Ground-based sensor systems have blind spots and cannot reliably provide measurements. A space-based constellation is the answer, but placing spacecraft in orbit is expensive and solving the resource constraint problem is essential." The cislunar region presents unique challenges for space domain awareness applications. Competing gravitational forces from the Earth and the Moon create complex orbital dynamics, while the sheer distances involved make tracking difficult. When spacecraft and satellites perform maneuvers in this space or behave unexpectedly, current systems can lose track of them entirely. RCAT-CS will tackle these problems by designing constellations of space-based sensors that can dynamically reposition themselves based on what they're observing. Professor Singh and his colleagues will develop novel algorithms to detect maneuvers made by tracked objects, balance fuel costs, track performance of the sensing satellites, and quantify the uncertainties underlying it all. The system addresses critical safety and security needs as cislunar space becomes increasingly congested and contested. The research will also advance fundamental knowledge in orbital dynamics and autonomous space systems, with implications for mission planning, collision avoidance, and safe coordination of a growing cislunar economy. Additionally, the project will train the next generation of space engineers in cutting-edge technologies essential for American leadership in space operations. “Congratulations to Professor Sandeep Singh and his team on securing a research grant in the important area of lunar space exploration,” said Shekhar Garde, Ph.D., the Thomas R. Farino Jr. ’67 and Patricia E. Farino Dean of the School of Engineering. “RPI has always been at the frontier of space exploration, from George Low’s work on the Apollo program to the forthcoming Artemis II mission, led by Commander Reid Wiseman ’97.” “Professor Singh’s work will not only advance research, it will strengthen RPI’s recently launched Aerospace Engineering undergraduate program by bringing the latest research into our classrooms,” Garde added. Looking to know more? Shekhar Garde, Ph.D. is available to discuss this topic. Simply click on his icon now to arrange an interview today.
Avoiding the Reverse Mortgage Reflex
Every once in a while, an industry article really hits the mark. Recently, one did just that—Canadian Mortgage Trends' "Who Uses Mortgage Brokers Today and Why? (Part 2)" gave seniors their own category, not as an afterthought, but as a client segment worthy of attention. Bravo. It's about time someone acknowledged that older Canadians aren't just "another niche." But then… came the reverse mortgage section. Don't get me wrong—it's refreshing to see financial professionals finally acknowledge that Canada's aging population presents both opportunities and complexities. But suggesting that "helping seniors" automatically means "offering a reverse mortgage" is like telling everyone who's thirsty to drink espresso. Some will love it. Others will lie awake at 3 a.m. with regrets. Let's call it what it is: type-casting seniors into a product. The Reverse Mortgage Reflex There's a curious habit in our industry. Mention the word "senior" and watch what happens: eyes light up, marketing decks shuffle, and—as if on cue—the term "reverse mortgage" materializes like a pop-up ad from 2007. It's as if the entire profession has agreed that every retiree with a pulse and property must be yearning to re-mortgage their home. Except… most aren't. Most seniors spent decades teaching their kids to avoid debt and pay off mortgages as quickly as possible CBC Radio. Suggesting they should now joyfully jump back into one to "solve retirement" isn't just unappealing—it's borderline insulting. Here's the truth: no one dreams of retiring into debt. And the numbers bear this out. Debt Levels: While only about a quarter of people over 65 had debt in the late 1990s, that figure has climbed to more than 40% today (Source: CBC News). Anxiety Levels: Nearly 50% of retirees now worry about their debt, according to the Credit Counselling Society. Reverse mortgages can absolutely be valuable tools. The reverse mortgage market has exploded, with over $8.2 billion in outstanding debt as of June 2024—an 18.3% increase from the previous year (Source: MoneySense). But offering one before understanding the client's full picture isn't being a trusted advisor—it's running on sales autopilot. Brokers, You're Better Than This Brokers pride themselves on being client advocates—the ones who shop the market, decode fine print, and find creative solutions when banks can't. The very definition of a broker is someone who matches the right solution to the customer's needs. So why, when it comes to seniors, do many skip the most important part—the needs assessment—and leap straight to the product? It's backwards. While it may seem very simple, a proper financial conversation starts with identifying the problem, then illustrating a solution, and finally defining the intended outcome. • Why does this person need to access equity? • What problem are they really solving? • How do they define "financial comfort" The first step of solution selling isn't talking—it's listening. Start With the Need, Not the Product Before reaching for any rate sheet, it's critical to understand the client's true priorities. According to research from HomeEquity Bank, 9 in 10 Canadians want to age in place and live out their retirement years in the comfort of their home (Source: Canadian Mortgage Trends). But their financial needs are as diverse as their travel insurance policies. The reality is stark: A 2024 survey by the Healthcare of Ontario Pension Plan (HOOPP) found that 39% of Canadians aged 55-64 have less than $5,000 in savings, and 73% have $100,000 or less. More than half of Canadians over 60 who remain in the workforce do so out of financial necessity, not choice (Source: CBC Radio). Ask the right questions: • Do they need to eliminate high-interest debt? • Do they need cash flow to cover rising expenses? • Are they struggling to afford in-home care or medical support? • Do they want income stability—that pension-like feeling—rather than a lump sum? • Do they want to downsize, relocate, or age in place with dignity? Only after understanding the full financial picture can you propose the best, most robust solution. That's not just good practice. That's respectful advising. Solution Selling: Connecting the Dots Here's a classic example: A client walks in with a paid-off home and a stack of monthly bills that feel heavier than the Sunday paper. They're anxious about cash flow but debt-averse. The reflex answer? "Reverse mortgage!" Not so fast. Solution sellers focus on understanding customers' challenges and delivering ideas that address their daily needs, rather than pushing products. When clients can see exactly what they're getting, they make better decisions and advisors earn lasting trust through transparency, not sales pressure. Maybe downsizing to a more manageable property makes sense. Perhaps a small secured line of credit covers the gap without interest compounding as quickly. Maybe an annuity provides steady income with less long-term cost. Or maybe—just maybe—they don't need a mortgage at all. Consider that a $100,000 reverse mortgage balance can grow to $150,000 in just 5 years at current rates, with interest compounding annually. When you solve the real problem (not just the balance sheet), you build lasting trust and genuine loyalty. The Psychology of the Senior Client It's not just about the math; it's about the mindset. Here's where most brokers stumble: they treat all seniors as if they're cut from the same cloth. They're not. Let's get real: seniors aren't a monolithic group. A 55-year-old and an 85-year-old? They're separated by 30+ years of life experience, different communication styles, varying financial literacy, and completely different emotional triggers around money. Cookie-cutter advice doesn't cut it. The best advisors listen first. They ask questions. They assess each client's actual financial situation—not what they assume it is—and then deliver advice that fits that person's life, not some generic "senior strategy." Respect Is the Real Differentiator Understanding a client's lifestyle, fears, and goals isn't just good ethics—it's good business. Seniors have finely tuned radar for sincerity. They can smell a sales pitch faster than a Labrador finds bacon. Want to stand out? Lead with curiosity, not a contract A holistic, solution-based approach positions you as a trusted advisor—not a product pusher. Once you earn that trust, referrals flow like coffee at a church social. From Product Pushing to Purpose Selling Here's the shift our industry needs: Stop viewing seniors as a market. Start viewing them as individuals with layered needs. Solution selling isn't anti-reverse mortgage—it's anti-assumption. It ensures the whole problem gets solved, not just the one that fits your product lineup. Yes, over 25% of Canadians aged 55 and older are considering a reverse mortgage (Source: Canadian Mortgage Trends), and it might eliminate a monthly payment—but if it doesn't solve for cash flow, health costs, or income stability, you've only done half the job. The real opportunity? Elevate the conversation from product placement to purpose-driven advising. Advisors, Reset Your Lens Seniors don't need to be sold. They need to be understood. Give them the dignity of choice, the respect of time, and the power of informed decision-making. When advisors show prospective clients detailed solutions, it allows clients to properly assess the quality of advice and make fully informed decisions, supporting healthy long-term relationships The best brokers—the ones shaping the next chapter of this industry—don't just sell mortgages. They sell confidence, clarity, and control. And that, my friends, is how you truly help Canadians retire hip, fit, and financially free. Want to become an expert on serving the senior demographic? Just message me to be notified about the next opportunity to become a "Certified Equity Advocate" — mastering solution-based advising that transforms how you work with Canada's fastest-growing client segment.
In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in lung cancer. The approach restores drug sensitivity and slows tumor growth. The findings were published Nov. 13, 2025 in the online edition of Molecular Therapy Oncology. This breakthrough stems from more than a decade of research by the Gene Editing Institute into the NRF2 gene, a known driver of treatment resistance. The results were consistent across multiple in vitro studies using human lung cancer cell lines and in vivo animal models. “We’ve seen compelling evidence at every stage of research,” said Kelly Banas, Ph.D., lead author of the study and associate director of research at the Gene Editing Institute. “It’s a strong foundation for taking the next step toward clinical trials.” Potential Beyond Lung Cancer The study focused on lung squamous cell carcinoma, an aggressive and common form of non-small cell lung cancer (NSCLC) that accounts for 20% to 30% of all lung cancer cases, according to the American Cancer Society. It’s estimated that over 190,000 people in the U.S. will be diagnosed in 2025. While the research centered on this cancer type, the implications are broader. Overactive NRF2 contributes to chemotherapy resistance in several solid tumors, including liver, esophageal and head and neck cancers. The results suggest a CRISPR-based strategy targeting NRF2 could help resensitize a wide range of treatment-resistant tumors to standard chemotherapy. “This is a significant step toward overcoming one of the biggest challenges in cancer therapy — drug resistance,” Banas said. “By targeting a key transcription factor that drives resistance, we’ve shown that gene editing can re-sensitize tumors to standard treatment. We’re hopeful that in clinical trials and beyond, this is what will allow chemotherapy to improve outcomes for patients and could enable them to remain healthier during the entirety of their treatment regimen.” Targeting a Master Switch for Resistance The research zeroed in on a tumor-specific mutation, R34G, in the NRF2 gene, which acts as a master regulator of cellular stress responses. When overactive, NRF2 helps cancer cells withstand chemotherapy. Using CRISPR/Cas9, the team engineered lung cancer cells with the R34G mutation and successfully knocked out NRF2. This restored sensitivity to chemotherapy drugs such as carboplatin and paclitaxel. In animal models, tumors directly treated with CRISPR to knockout NRF2 grew more slowly and responded better to treatment. “This work brings transformational change to how we think about treating resistant cancers,” said Eric Kmiec, Ph.D., senior author of the study and executive director of the Gene Editing Institute. “Instead of developing entirely new drugs, we are using gene editing to make existing ones effective again.” Editing Reaches Threshold Levels One of the most promising discoveries was that disrupting NRF2 in just 20% to 40% of tumor cells, was enough to improve the response to chemotherapy and shrink tumors. This insight is particularly relevant for clinical use, where editing every cancer cell may not be feasible. To test therapy in mice, the researchers used lipid nanoparticles (LNPs), a non-viral method with high efficiency and low risk of unintended, off-target effects. Sequencing confirmed that the edits were highly specific to the mutated NRF2 gene, with minimal unintended changes elsewhere in the genome. “The power of this CRISPR therapy lies in its precision. It’s like an arrow that hits only the bullseye,” said Banas. “This level of specificity with minimal unanticipated genomic side effects offers real hope for the cancer patients who could one day receive this treatment.”
A new study into how spaceflight impacts the human brain and eyes revealed notable sex differences in brain fluid shifts, with female astronauts showing a greater reduction in fluid around the uppermost part of the brain than their male counterparts. Led by Rachael D. Seidler, Ph.D., director of the University of Florida’s Astraeus Space Institute and professor of applied physiology and kinesiology, the study analyzed data from astronauts to determine how factors such as sex, age and body metrics relate to structural brain and eye changes after space travel. The findings, published in August in npj Microgravity, provide key information for protecting astronaut health on long-duration missions to the moon and Mars. This is one of the first studies to look at sex differences in the physiological response to spaceflight. “The data on sex differences in response to spaceflight are scant, given the historically low number of female astronauts.” — Rachael D. Seidler, Ph.D., director of the University of Florida’s Astraeus Space Institute In addition to changes in fluid around the brain, the team also found that a form of eye compression, a hallmark of Spaceflight Associated Neuro-ocular Syndrome known as globe flattening, was the most consistent eye change among crew members. “By far the most prevalent sign of eye changes that we observed was globe flattening, suggesting that this should be the primary monitoring target for ocular health,” Seidler said. “Interestingly, eye changes were more prevalent in males than females.” Globe flattening, when the back of the eyeball becomes slightly indented or pushed inward, might sound minor, but it can have significant effects on vision and raise concerns for long-duration space missions. Surprisingly, there was no strong link between brain structural changes and eye changes, suggesting that the effects on the eyes and brain may arise from distinct mechanisms rather than shared physiological causes. The research underscores UF’s growing leadership in space health science. Through the Astraeus Space Institute, Seidler leads multidisciplinary collaborations that connect neuroscience, physiology and space research to advance human performance and safety in spaceflight. “We used UF's HiPerGator computing cluster for our analyses in this study, enabling us to analyze our data at high speeds,” Seidler said. Read the full study in npj Microgravity.
